Table 1.
General Features | HIV/HTLV-1 (n = 29) |
HIV (n = 59) |
HC (n = 16) |
p value |
---|---|---|---|---|
Age, years | ||||
Median | 40.0 | 41.0 | 32.0 | |
IQR | 34.0 - 48.0 | 32.0 - 47.0 | 29.0 - 38.0 | 0.123* |
Gender | ||||
Male | 4 (13.8%) | 8 (13.6%) | 12 (80%) | |
Female | 25 (86.3%) | 51 (86.4%) | 3 (20%) | 0.000** |
HIV clinical stage*** | ||||
I | 7 (24.1%) | 14 (23.7%) | ||
II | 17 (58.4%) | 33 (56.0%) | ||
III | 5 (17.2%) | 12 (20.3%) | 0.587** |
* One Way Anova; ** Chi square; ***as defined by WHO[30];
HIV/HTLV-1, HIV/HTLV-1 co-infected; HIV, HIV mono-infected; HC, healthy controls